Amphastar Pharmaceuticals, Inc.
AMPHNASDAQ · Healthcare · Drug Manufacturers - Specialty & GenericCheapAmphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and in…
$28.49+3.00%
报价 2026-11-06
市值
$1.21B
EV
$1.37B
PE (TTM)
9.0x
预期 PE (FY2026)
9.6x
52 周区间距高点 -3.1%
$16.87$29.40
筛选结果
pipeline · 2026-11-06Keep✗ 高增长✓ Cheap✗ GARP
Cheap Pool: PE <= 12, EV/EBITDA <= 8, P/FCF <= 12
爆发潜力
2026-11-07未命中✗ 收入线✗ EPS 线
| 财年 | 收入倍数 | EPS | PE |
|---|---|---|---|
| FY+22027-12 | 1.1x | 3.20 → 3.17（1.0x） | 9.0 |
| FY+32028-12 | 1.1x | 3.20 → 3.36（1.1x） | 8.5 |
毛利率 49% · TTM 收入 $746M · 基数 EPS 3.20（调整后）
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| AMPHAmphastar Pharmaceuticals, Inc. | $1.21B | +3.0% | +3.6% | 49.5% | 9.0x | 7.0x | 10.0x | Cheap |
| PCRXPacira BioSciences, Inc. | $1.45B | +0.0% | +3.3% | 77% | 103.2x | 14.4x | 8.1x | |
| INBXInhibrx Biosciences, Inc. | $1.24B | +5.3% | +230.8% | 0% | – | – | – | |
| HROWHarrow Health, Inc. | $1.01B | +3.3% | +27.9% | 71.3% | – | 109.5x | 177.3x | GARP |
| AHCOAdaptHealth Corp. | $999.4M | -1.1% | -10.8% | 15.4% | – | 36.8x | 12.2x | |
| SNDXSyndax Pharmaceuticals, Inc. | $858.9M | +1.8% | +107.0% | 96% | – | – | – | |
| COLLCollegium Pharmaceutical, Inc. | $788.2M | -3.8% | +11.9% | 59.4% | 17.5x | 3.0x | 2.4x | Cheap GARP |
| BBNXBeta Bionics, Inc. | $706.3M | +1.4% | +35.5% | 58.6% | – | – | – | 高增长 |
| EMBCEmbecta Corp. | $350.7M | -2.2% | +4.3% | 59.9% | 3.3x | 5.8x | 1.8x | Cheap |
| 同行中位数 | – | – | +19.9% | 59.6% | 17.5x | 14.4x | 8.1x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。